ArticleJournal of surgical case reports2026
Robot-assisted total laparoscopic pancreaticoduodenectomy with transvaginal specimen extraction: a case report.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural orifice specimen extraction surgery reduces incision-related complications and accelerates postoperative recovery while maintaining oncologic safety, whereas the da Vinci robotic surgical system further enhances the precision of minimally invasive procedures. This case report describes a robot-assisted total laparoscopic pancreaticoduodenectomy combined with transvaginal specimen extraction (RPD-TVSE). The patient was a 64-year-old female with moderately differentiated adenocarcinoma of the descending duodenum. The procedure took 350 min, with intraoperative blood loss of 200 mL; no blood transfusion was administered during the perioperative period. The patient was able to ambulate on postoperative day 1, with no adverse events recorded. Histopathology confirmed tumor staging as pT2N0M0, with all surgical margins negative. At 12-month follow-up, no evidence of recurrence was observed. This case demonstrates that RPD-TVSE is technically feasible and yields favorable short-term outcomes, providing a novel minimally invasive surgical option for female patients. However, long-term oncologic safety requires further investigation and validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.